BIOTECH CONSULT: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BIOTECH CONSULT
Largest movements
- Receivables within one year +€88,244
up €88,244 (+373%), from €23,671 to €111,915
of which Trade receivables: +€88,015
- Cash +€22,336
up €22,336 (+17.0%), from €131,412 to €153,748
mainly Net result for the year (+€72,378) and Trade debts (+€37,232)
- Reserves +€71,519
up €71,519 (+33.3%), from €214,891 to €286,410
of which Distributable reserves: +€71,519
- Trade debts +€37,232
up €37,232 (+1,088%), from €3,422 to €40,654
- Tax, wage and social debts +€15,364
up €15,364 (+65.8%), from €23,358 to €38,722
of which Taxes: +€17,164
- Other debts -€12,372
down €12,372 (-96.0%), from €12,884 to €511
- Gross operating margin -€12,263
down €12,263 (-10.1%), from €121,988 to €109,725
- Other operating charges -€3,160
down €3,160 (-66.6%), from €4,743 to €1,582
- Taxes +€1,932
up €1,932 (+6.3%), from €30,654 to €32,586
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €282,015 | €393,807 | +€111,792 | +39.6% |
| Fixed assets | 21/28 | €125,727 | €126,277 | +€551 | +0.4% |
| Tangible fixed assets | 22/27 | €105,639 | €106,189 | +€551 | +0.5% |
| Land and buildings | 22 | €104,954 | €104,252 | -€702 | -0.7% |
| Furniture and vehicles | 24 | €685 | €1,938 | +€1,252 | +183% |
| Financial fixed assets | 28 | €20,088 | €20,088 | = | 0.0% |
| Current assets | 29/58 | €156,288 | €267,529 | +€111,242 | +71.2% |
| Amounts receivable within one year | 40/41 | €23,671 | €111,915 | +€88,244 | +373% |
| Trade receivables | 40 | €23,671 | €111,686 | +€88,015 | +372% |
| Other amounts receivable | 41 | - | €229 | +€229 | |
| Cash at bank and in hand | 54/58 | €131,412 | €153,748 | +€22,336 | +17.0% |
| Deferred charges and accrued income | 490/1 | €1,205 | €1,866 | +€661 | +54.8% |
| Total equity and liabilities | 10/49 | €282,015 | €393,807 | +€111,792 | +39.6% |
| Equity | 10/15 | €230,826 | €302,345 | +€71,519 | +31.0% |
| Contributions | 10/11 | €15,935 | €15,935 | = | 0.0% |
| Reserves | 13 | €214,891 | €286,410 | +€71,519 | +33.3% |
| Tax-exempt reserves | 132 | €74,235 | €74,235 | = | 0.0% |
| Distributable reserves | 133 | €140,656 | €212,175 | +€71,519 | +50.8% |
| Provisions and deferred taxes | 16 | €10,125 | €10,125 | = | 0.0% |
| Deferred taxes | 168 | €10,125 | €10,125 | = | 0.0% |
| Amounts payable | 17/49 | €41,063 | €81,337 | +€40,274 | +98.1% |
| Amounts payable within one year | 42/48 | €39,663 | €79,887 | +€40,224 | +101% |
| Trade debts | 44 | €3,422 | €40,654 | +€37,232 | +1,088% |
| Suppliers | 440/4 | €3,422 | €40,654 | +€37,232 | +1,088% |
| Taxes, remuneration and social security | 45 | €23,358 | €38,722 | +€15,364 | +65.8% |
| Taxes | 450/3 | €21,558 | €38,722 | +€17,164 | +79.6% |
| Remuneration and social security | 454/9 | €1,800 | - | -€1,800 | |
| Other amounts payable | 47/48 | €12,884 | €511 | -€12,372 | -96.0% |
| Accrued charges and deferred income | 492/3 | €1,400 | €1,450 | +€50 | +3.6% |
| Non-recurring operating income | 76A | - | €254 | +€254 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,762 | €3,953 | +€1,191 | +43.1% |
| Other operating charges | 640/8 | €4,743 | €1,582 | -€3,160 | -66.6% |
| Gross operating margin | 9900 | €121,988 | €109,725 | -€12,263 | -10.1% |
| Operating profit (loss) | 9901 | €114,483 | €104,190 | -€10,293 | -9.0% |
| Financial income | 75/76B | €36 | €918 | +€882 | +2,459% |
| Recurring financial income | 75 | €36 | €918 | +€882 | +2,459% |
| Financial charges | 65/66B | €272 | €144 | -€128 | -47.1% |
| Recurring financial charges | 65 | €272 | €144 | -€128 | -47.1% |
| Profit (loss) for the period before taxes | 9903 | €114,247 | €104,964 | -€9,283 | -8.1% |
| Income taxes | 67/77 | €30,654 | €32,586 | +€1,932 | +6.3% |
| Profit (loss) for the period | 9904 | €83,592 | €72,378 | -€11,215 | -13.4% |
| Transfer to tax-exempt reserves | 689 | €25,260 | - | -€25,260 | |
| Profit (loss) for the period to be appropriated | 9905 | €58,332 | €72,378 | +€14,045 | +24.1% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.